Article citationsMore>>

Glassman, D.T., Chon, J.K., Borkowski, A., Jacobs, S.C. and Kyprianou, N. (2001) Combined Effect of Terazosin and Finasteride on Apoptosis, Cell Proliferation, and Transforming Growth Factor-Beta Expression in Benign Prostatic Hyperplasia. The Prostate, 46, 45-51. http://dx.doi.org/10.1002/1097-0045(200101)46:1<45::AID-PROS1007>3.0.CO;2-U

has been cited by the following article:

• TITLE: Plasma Kinetic Resection of Prostate Combined Terazosin for Treatment of BPH Patient with Coexisting Hypertension

  AUTHORS: Ming Zheng, Mingqiang Zeng, Chonghe Jiang, Jinyang Chen, Shuren Li, Jiaxin Wang

  KEYWORDS: Benign Prostatic Hyperplasia, Hypertension, Terazosin, Plasma Kinetic Vaporization of the Prostate

  JOURNAL NAME: Open Journal of Urology, Vol.4 No.5, May 28, 2014

  ABSTRACT: Objective: To evaluate the efficacy and safety of terazosin and plasma kinetic resection of the prostate (PKRP) in the treatment of benign prostatic hyperplasia (BPH) patients with coexisting hypertension. Methods: A total of 205 men who suffered from BPH with concomitant hypertension were enrolled in this study. They all received PKRP surgery and terazosin medication from one week before to 3 months after the operation. The procedures of efficacy and safety were evaluated by analysis of the changes in blood pressures, IPSS, Qmax and the drug related adverse events 4 weeks and 3 months after the operation. Results: The systolic blood pressure decreased from 161 ± 12.33 mmHg at baseline to 148 ± 7.27 mmHg four weeks (PPPPPPP